Laserfiche WebLink
INTRODUCTION <br />Distributed upstream retention is established by the Red River Basin Commission’s Long Term Flood Solutions Report <br />(RRBC LTFS) as one component of the overall strategy to provide flood protection for the Red River Basin. The RRBC <br />completed the Halstad Upstream Retention (HUR) Study to analyze regional impacts of locally identified <br />impoundment locations on the Red River mainstem above Halstad, MN. <br />Since completion of the HUR Study, the Fargo-MoorheadMetro Flood Diversion Authority (FMDAMFDA) has <br />allocated a total $24.5 million to further incentivize development and implementation of impoundments located in <br />the Red River Basin above Halstad, MN. This document establishes the criteria and procedure for determining <br />funding eligibility for FMDAMFDA funds. <br />Funding proposals should be sent to: <br />Fargo-Moorhead Diversion Authority <br />Attention: Keith Berndt, County Administrator <br />Cass County, ND <br />211 9th Street S <br />PO Box 2806 <br />Fargo, ND 58108-2806 <br />berndtk@casscountynd.gov <br /> <br />SECTION I – General Criteria <br />Below lists general criteria to qualify for FMDAMFDA funds. Proposed impoundments must meet all of listed items <br />to meet eligibility for FMDAMFDA funding: <br />• Qualifying impoundments must detain flood waters within the Red River Basin above USGS Gage 05064500 <br />(Red River of the North at Halstad, MN). <br />• Qualifying Project Sponsors include: <br />o Watershed Districts (Minnesota) <br />o County Water Resource Districts (North Dakota) <br />o Joint Powers Authorities which include membership from Watershed Districts and/or Water <br />Resource Districts <br />• The proposed impoundment site must be identified prior to submission. <br />• Proposed Impoundments must provide a minimum of 1,000 acre-feet of combined gated storage and un- <br />gated storage during the HUR Study Standardized Melt Progression Event. <br />A summary of FMDAMFDA Funding Eligibility and Process is provided on the next page, as well as discussed in greater <br />detail in the following sections. <br /> <br /> 2 <br />MFDA_Funding_Policy_Final-R1_2015-1217.docx